ISRCTN41688895进行中（未招募）Unknown
Progression in Multiple Sclerosis
适应症
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 入组人数
- 10,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. A locally confirmed diagnosis of multiple sclerosis
- •2. At least one measure of Extended Disability Severity Score (EDSS)
- •3. Able to give valid informed consent
排除标准
- •1. Patients with Radiologically or Clinically Isolated Syndrome (RIS or CIS)
- •2. Comorbidities causing significant disability likely to have confounded the reliability of the EDSS
- •3. Inclusion in the discovery cohort of the recently completed first progression GWAS
研究者
相似试验
尚未招募
3 期
Treatment of Progressive Multiple Sclerosis-related Cognitive Impairment, Fatigue, and Depression Using Repetitive Transcranial Magnetic StimulatioNervous System DiseasesPACTR202403516079512Science Technology and Innovation Funding Authority60
进行中（未招募）
1 期
Phase IIIB-IV long term follow-up study for patients who participated in CAMMS03409Relapsing-remitting multiple sclerosisMedDRA version: 21.1Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2013-003884-71-CZGenzyme Corporation1,248
进行中（未招募）
1 期
Phase IIIB-IV long term follow-up study for patients who participated in CAMMS03409EUCTR2013-003884-71-ITGenzyme Corporation799
进行中（未招募）
1 期
Phase IIIB-IV long term follow-up study for patients who participated in CAMMS03409Relapsing-remitting multiple sclerosisMedDRA version: 21.1Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2013-003884-71-NLGenzyme Corporation1,248
进行中（未招募）
1 期
Phase IIIB-IV long term follow-up study for patients who participated in CAMMS03409EUCTR2013-003884-71-DKGenzyme Corporation1,248